Literature DB >> 20808209

Pros and cons of composite endpoints in anesthesia trials.

Paul S Myles, Philip J Devereaux.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20808209     DOI： 10.1097/ALN.0b013e3181ee2ceb

Source DB:  PubMed          Journal:  Anesthesiology        ISSN： 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  7 in total

1.  One more brick in the wall of protective ventilation in surgical patients.

Authors:  Roberto Rabello Filho; Ary Serpa Neto
Journal:  Ann Transl Med       Date:  2015-12

Review 2.  Individual and composite study endpoints: separating the wheat from the chaff.

Authors:  Robert Goldberg; Joel M Gore; Bruce Barton; Jerry Gurwitz
Journal:  Am J Med       Date:  2014-01-28       Impact factor: 4.965

Review 3.  Meaningful outcome measures in cardiac surgery.

Authors:  Paul S Myles
Journal:  J Extra Corpor Technol       Date:  2014-03

Review 4.  Multiobjective optimization challenges in perioperative anesthesia: A review.

Authors:  Meghan Brennan; Jack D Hagan; Chris Giordano; Tyler J Loftus; Catherine E Price; Haldun Aytug; Patrick J Tighe
Journal:  Surgery       Date:  2020-12-14       Impact factor: 4.348

5.  Measurement of patient reported disability using WHODAS 2.0 before and after surgical intervention in Madagascar.

Authors:  Michelle C White; Kirsten Randall; Dennis Alcorn; Rachel Greenland; Christine Glasgo; Mark G Shrime
Journal:  BMC Health Serv Res       Date:  2018-04-27       Impact factor: 2.655

6.  Validation of days at home as an outcome measure after surgery: a prospective cohort study in Australia.

Authors:  Paul S Myles; Mark A Shulman; Stephane Heritier; Sophie Wallace; David R McIlroy; Stuart McCluskey; Isabella Sillar; Andrew Forbes
Journal:  BMJ Open       Date:  2017-08-18       Impact factor: 2.692

7.  Achieving the composite endpoint of glycated haemoglobin <7.0%, no weight gain and no hypoglycaemia in the once-weekly dulaglutide AWARD programme.

Authors:  K M Dungan; I Raz; Z Skrivanek; W Sealls; J L Fahrbach
Journal:  Diabetes Obes Metab       Date:  2015-11-03       Impact factor: 6.577
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.